Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Znegui (sfax, Tunisia), M. Nadia (Sfax, Tunisia), N. Mahmoud (Sfax, Tunisia), K. Amina (Sfax, Tunisia), K. Nesrin (Sfax, Tunisia), G. Rahma (Sfax, Tunisia), B. Najla (Sfax, Tunisia), F. Walid (Sfax, Tunisia), M. Sameh (Sfax, Tunisia), Y. Ilhem (Sfax, Tunisia), A. Hajer (Sfax, Tunisia), K. Wajdi (Sfax, Tunisia), K. Sami (Sfax, Tunisia). Associations between comorbidities and survival in patients with interstitial lung diseases. 2342

Member's Comments

No comment yet.

Related content which might interest you: Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases – a claims data analysis Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 The associations of interstitial lung abnormalities with cancer diagnoses and mortality Source: Eur Respir J, 56 (6) 1902154; 10.1183/13993003.02154-2019 Year: 2020 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Comorbidities in interstitial lung diseases Source: Eur Respir Rev 2017; 26: 160027 Year: 2017 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 Cardiovascular comorbidity in Danish patients with scleroderma-associated interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies Source: International Congress 2016 – Connective tissue disorders Year: 2016 The relationship between comorbidities and systemic inflammation in patients with COPD Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry Source: International Congress 2016 – IPF clinical Year: 2016 Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease Source: International Congress 2015 – Connective tissue disorders Year: 2015 Interstitial lung diseases, mortality and associated risk factors Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Clinical characteristics of patients with unclassifiable interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Predictors of progression in systemic sclerosis patients with interstitial lung disease Source: Eur Respir J, 55 (5) 1902026; 10.1183/13993003.02026-2019 Year: 2020 Post-surgery complications in patients with chronic lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 735s Year: 2006 Surgical morbidity and mortality in lung cancer patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 782s Year: 2006 Frequency and impact of interstitial lung disease on clinical state and mortality in systemic scleroderma Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012